AMPE Description — Ampio Pharmaceuticals Inc
Ampio Pharmaceuticals is a biopharmaceutical company focused on the research, development and improvement of immunomodulatory therapies for the treatment of pain from osteoarthritis. Ampion, Co.'s primary product candidate is a biologic drug, which contains ingredients that target several pathways in the innate immune response characteristic of inflammatory disease. Ampion is in development as an intra-articular injection treatment for severe Osteoarthritis of the Knee; an intravenous and inhaled treatment for COVID-19 patients; and an at-home inhalation treatment for patients with prolonged respiratory symptoms due to COVID-19.